Biotechnology Fundraising Reflects Bigger Start-Ups, Fewer IPOs in 2005
This article was originally published in Start Up
Executive Summary
Fundraising among private biotechs has evened out this year, with larger early rounds reflecting the renewed "think-big" strategy of some start ups, and larger late rounds a consequence of less receptive IPO markets.